FDMT - 4D Molecular Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FDMT is currently covered by 7 analysts with an average price target of $35.34. This is a potential upside of $27.22 (335.22%) from yesterday's end of day stock price of $8.12.

4D Molecular Therapeutics 's activity chart (see below) currently has 8 price targets and 42 ratings on display. The stock rating distribution of FDMT is 8.11% HOLD and 91.89% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.55% with an average time for these price targets to be met of 88.43 days.

Highest price target for FDMT is $81, Lowest price target is $36, average price target is $35.34.

Most recent stock forecast was given by JOSH SCHIMMER from CANTOR FITZGERALD on 23-Sep-2024. First documented stock forecast 05-Jan-2021.

Currently out of the existing stock ratings of FDMT, 3 are a HOLD (8.11%), 34 are a BUY (91.89%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1 months 17 days ago
(23-Sep-2024)

1/3 (33.33%)

$21.48 (204.18%)

104

Buy

$36

$27.9 (344.44%)

$24

1 months 21 days ago
(19-Sep-2024)

7/8 (87.5%)

$21.83 (154.06%)

285

Buy

$36

$27.9 (344.44%)

$36

1 months 21 days ago
(19-Sep-2024)

0/13 (0%)

$21.83 (154.06%)

Buy

$39

$30.9 (381.48%)

$38

1 months 21 days ago
(19-Sep-2024)

3/5 (60%)

$24.83 (175.23%)

201

Buy

$40

$31.9 (393.83%)

$40

3 months 18 days ago
(22-Jul-2024)

2/5 (40%)

$22.92 (134.19%)

29

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?

On average it took 88.43 days on average for the stock forecasts to be realized with a an average price target met ratio 31.55

Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

GEULAH LIVSHITS

Which analyst has the current lower performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?

Geulah Livshits works at CHARDAN CAPITAL and has 3 price targets and 3 ratings on FDMT

Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?

Salveen Richter with highest potential upside - $72.9

Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?

Josh Schimmer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?